Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Grand Pharmaceutical Group Limited ( (HK:0512) ) just unveiled an update.
Grand Pharmaceutical Group Limited has announced a board meeting scheduled for March 12, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024, and to discuss the payment of a final dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting stakeholders’ expectations and the company’s market positioning.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating in the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products and services.
YTD Price Performance: 8.12%
Average Trading Volume: 3,282,049
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$18.42B
See more insights into 0512 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue